Recipharm AB has acquired Abbott’s (formerly Solvay Pharmaceuticals) manufacturing site in Parets, close to Barcelona, Spain. Parets produces solid dose, sterile ointments, oral liquids, aerosols and topical products. The newly acquired business will be called Recipharm Parets SL. Financial details were not disclosed.

The acquisition adds to Recipharm’s capabilities and provides entry into the Spanish market. Recipharm will continue to produce all Abbott products currently manufactured at the site. Recipharm also plans to retain all existing employees.

Thomas Eldered, chief executive officer of Recipharm, said, “We are extremely pleased to be entering into another transaction with Abbott and to be building on the successful integration of the Fontaine les Dijon facility which we acquired last year from former Solvay Pharmaceuticals. Both the facilities and staff are first class and we look forward to nurturing and developing current and new business in the important Spanish market.”